IL-23 is secreted by both macrophages and dendritic cells as a host defense and wound healing response. It has been implicated in several inflammatory and autoimmune diseases, including psoriasis, psoriatic arthritis, Crohn’s Disease and ankylosing spondylitis. Genome-wide association studies (GWAS) have also linked IL-23 to ulcerative colitis, inflammatory bowel disease (IBD) and graft-versus-host disease.2
This Sword Assay has been optimized for use with the R&D Systems Quantikine ELISA for Human IL-23 (Catalog No. D2300B).
Contact the Sword team today to discuss how best to implement our Human IL-23 assay for your needs.